Alligator Bioscience

Alligator Bioscience AB (Lund, Sweden) is an early-stage drug discovery and development company focusing on immunotherapy of cancer. Compared to conventional systemic immunotherapy, Alligator has pioneered a new treatment concept aiming at local administration. The treatment concept is expected to result in better efficacy and fewer adverse events compared to systemically administered immunotherapies.
Peter Benson, MSc

Chairman & General Partner

Mobile: +45 40 80 48 69